Recent Progresses of Oncolytic ImmunotherapyJean-François Fonteneau*
Institute of Health Research of the University of Nantes, 8 Quai Moncousu, BP70721, 44007, Nantes Cedex1, France
- *Corresponding Author:
- Jean-François Fonteneau
Institute of Health Research of the University of Nantes
8 Quai Moncousu, BP70721, 44007, Nantes Cedex1, France
E-mail: [email protected]
Received date: September 24, 2015 Accepted date: September 28, 2015 Published date: October 5, 2015
Citation: Fonteneau JF (2015) Recent Progresses of Oncolytic Immunotherapy. Immunother open acccess 1:e101. doi:10.4172/2471-9552.1000e101
Copyright: © 2015 Fonteneau JF. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Oncolytic immunotherapy, also known as anti-tumor virotherapy, is a therapeutic approach using oncolytic viruses that preferentially or exclusively infect and kill tumor cells. In this short review, we discuss recent advances of this therapeutic strategy.